Mary Beth Hilton

Title: Mary Beth Hilton: Innovator in Antibody Research

Introduction

Mary Beth Hilton is a prominent inventor based in Thurmont, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins associated with various diseases.

Latest Patents

Mary Beth Hilton holds a patent for "TEM8 antibodies, conjugates thereof, and their use." This patent discloses antibodies that specifically bind to the TEM8 protein. The conjugates and antibodies described in her patent are useful for methods of detecting and treating pathogenic angiogenesis. Additionally, they have applications in detecting and treating cancer. Furthermore, these conjugates and antibodies can decrease the binding of Anthrax protective antigen to a cell.

Career Highlights

Throughout her career, Mary Beth Hilton has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. Her work in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.

Collaborations

Mary Beth has collaborated with notable colleagues, including Brad St. Croix and Tony Fleming. These partnerships have further enriched her research and innovation in the field of antibody development.

Conclusion

Mary Beth Hilton's work in antibody research exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her impact on the field and her commitment to improving health outcomes.